Hereditary Ataxia Diagnosis
Hereditary Ataxia Diagnosis
The diagnosis of hereditary ataxia rests on two facts and one test . The two facts are the inheritance pattern and the age at onset , and both are usually obtainable from the family before anyone is examined — which is why the most informative part of this assessment costs nothing and already exists. The examination establishes that the problem is coordination rather than weakness, and separates a purely cerebellar pattern from one in which the nerves and the posterior columns are involved. Imaging excludes rather than diagnoses. And the genetic test is chosen rather than exhaustive : a repeat-expansion test, a panel, or sequencing, picked because the pattern pointed at it. This page sets out each of those, the three shapes a result can take, and what a finished assessment leaves behind in writing.
Two facts, and why they decide the test
Two facts are established first, and together they decide which test is worth doing before any test is ordered. How does it run in the family? At what age did it begin?
They work because the groups differ on exactly these two axes. Adult onset with affected people in successive generations points at the dominant group, where a gene panel is the reasonable first test. Childhood or adolescent onset in a family where both parents are well points at the recessive group, where a repeat-expansion test for Friedreich ataxia is the reasonable first test. Episodes rather than a continuous decline point at the episodic ataxias, where the treatment rather than the surveillance is the answer. A wider multi-system picture points at the mitochondrial group, where a different set of investigations is used from the start.
What the two facts do not do is give the diagnosis. They decide which test is the right one rather than the largest one — and that distinction is the whole of the value here, because ordering every available test at once produces more results to explain and no more answers.
The reason they outrank the scan is not that the scan is useless. It is that the scan answers a different question: it says the cerebellum is involved and excludes what would be visible. It does not say which hereditary ataxia this is. How the pattern is recognised at home is set out on the symptoms page.
What the appointment asks, and how a family history is taken
The first appointment is largely a history, and the history here is a pedigree. What is being assembled is not a story but a chart: three generations, who was affected, at what age each became unsteady, how it progressed in each of them, and who is well.
The way it is asked matters more than the question. A general question — does anyone else in the family have this? — is usually answered no, and in this group it is answered no by families in which several people are affected. What works is going relative by relative, and asking about the descriptions families actually use: who was unsteady, who was clumsy, who was said to have a drink problem, who stopped walking distances, who used a stick early, who died of heart failure in middle age. Those are the relatives who carry the pattern, and none of them is described as having a disease.
Two questions are asked that people are frequently surprised by. The first is whether the parents are related by blood, which is asked without any implication and is the setting in which the recessive forms are most often found. The second is what has arrived outside the nervous system — the heart, glucose, the spine, hearing — because those are the features that place a family in the group carrying surveillance obligations.
What is also asked is what has already been done: which scans, in what year and with which sequences; which genetic tests, by which laboratory, and what the report actually said rather than what was understood from it. Where a previous report exists, it is the single most useful document a family can bring, and a summary of it is not a substitute.
The parts of the examination that carry the weight
Five things are done in the room, and each answers a question that no scan answers better.
Gait, stance and sitting. The person walks, turns, stops, and stands with the feet together, and then with the eyes closed. What is being established is whether the ataxia is of the limbs, of the trunk, or both — because the two are targeted differently in therapy — and how much vision is compensating.
Limb coordination. Reaching for a target, touching the nose, and rapid alternating movements. Overshoot that worsens as the target gets closer, and a tremor that appears during the movement rather than at rest, are the findings that distinguish a cerebellar tremor from a parkinsonian one.
Speech and swallowing. Speech is examined for the scanning quality that characterises cerebellar dysarthria, and where it has changed, swallowing is assessed rather than asked about. The reason is the reason given throughout this guide: the same muscles serve both, and the assessment is worth doing while it can be routine.
Reflexes, vibration and joint position sense. This is the part that separates the groups. Absent ankle reflexes together with an upgoing plantar, and loss of vibration and joint position sense, mean the peripheral nerves and the posterior columns are involved alongside the cerebellum — and that combination points at the recessive group rather than the dominant one.
The spine, the feet and the heart. Scoliosis, a high arch to the foot, and the heart are examined, because these are where the recessive forms declare themselves and because scoliosis and foot shape often precede the unsteadiness by years. This is the part of the examination most often left undone, and it is the part that carries the surveillance.
Which genetic test, and the three shapes of a result
Genetic testing here is chosen rather than exhaustive. Each test below looks at a different thing, and the pattern decides which is used first.
| Test | The question it answers | When it is not the first test |
|---|---|---|
| Repeat-expansion testing | Whether the specific expanded repeat responsible for Friedreich ataxia is present, where onset was in childhood or adolescence | Not first where onset was in adult life with a dominant family pattern |
| An ataxia gene panel | Whether a disease-causing variant is present in one of the many genes known to cause the dominant ataxias | Not first where the pattern points clearly at the recessive group |
| Exome or genome sequencing | A broader search, used where the pattern is unclear, where a panel has been negative, or where the picture spans several systems | Not first where a targeted test would answer it, because breadth here produces more findings to interpret |
| Testing of relatives to check segregation | Whether a variant found in one person travels with the condition in the family, which is how an uncertain result becomes a classified one | Not a substitute for an explanation. It is done with counselling, and with the relatives' own consent |
| Cardiac and endocrine testing in the recessive group | Not a genetic test. It is the surveillance the genotype dictates, performed on a schedule rather than for symptoms | Not optional once the pattern points at the recessive group |
| Swallowing assessment where speech has changed | Not a genetic test. It is the assessment that prevents the complication rather than reacting to it | Not deferred to the next appointment |
The three shapes a result takes. A disease-causing variant is found — which names the condition, ends the odyssey and switches surveillance on. No variant is found — which means the question has not been answered with the tests available, not that the cause is not genetic. Or a variant of uncertain significance, which means a change was found and the evidence is not yet sufficient to classify it, and which is the result most often misread in both directions. All three should be explained rather than handed over, and the explanation belongs before the sample is taken rather than after the report arrives.
What must be said about testing here: it is chosen from the pattern, and anything recommended that is not carried out within this pathway is named at the outset, before any payment is discussed. Where the right answer is that no further testing would change the management, that is said as plainly as the alternative. What changes once a name exists is set out on the treatment page.
When the test is negative, and what that changes
This is the section families come to a second opinion for, and the answer is narrower and more useful than most expect. A negative result does not mean the condition is not genetic, and it does not mean the ataxia is not real. It means no disease-causing variant was found by the test that was performed, and the tests differ greatly in what they look at and how deeply.
What it does change is the second decision rather than the first. The management of ataxia is guided by the pattern whether or not a name exists: the physiotherapy, the swallowing surveillance, the cardiac surveillance where the recessive pattern is present, and the home assessment are all indicated on the clinical picture rather than on the gene. So a negative result does not remove the plan — and where a family has been told that a negative test means nothing further can be done, that is the failure here rather than the result.
What must be separated, and frequently is not, is no variant found from a variant of uncertain significance. The first is an unanswered question. The second is a finding awaiting classification, and the way it is usually resolved is time plus segregation: re-examined at a defined interval against the evidence that has accumulated, and checked against whether it travels with the condition in the family.
Where the picture genuinely remains incomplete, the honest statement is that the question has not been answered yet, that the plan continues on the pattern, and that the question is revisited at a defined interval rather than closed. That is a real plan with a real endpoint, and it is worth more than another test ordered to fill the silence.
What a finished assessment leaves behind in writing
An assessment is not finished when the appointment ends. What should exist afterwards is a written statement of five things, and a family is entitled to ask for each of them.
First, which inheritance pattern this fits, and how confidently — including where the honest answer is that the history does not yet establish one. Second, which genetic test is the right next one, or the reasoning for why none would change the management. Third, what surveillance the pattern carries, inside the nervous system and outside it, with each item given an interval rather than a general instruction to keep an eye on it. Fourth, the score on a standard scale and the interval at which it will be repeated, so that progression is measured rather than recalled. Fifth, what the result means for the family — siblings, children and future pregnancies — with the recurrence risk stated as the definition of the inheritance mode rather than as a prediction about any individual.
Alongside it, a review at a defined interval: annually for the measured score, and on the schedule the genotype dictates for the heart and the metabolism. A vague instruction to come back if it is worse is not a plan, and it is the commonest way a slowly progressive condition in this group is left unmanaged.
A written opinion is returned within 48 hours of complete records arriving, and for a records-only review that means from the point the file is complete rather than from the point it is first sent. What treatment looks like once the pattern is named is set out on the treatment page.